These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35852599)

  • 21. Cutaneous Features, Autoantibody Profile, and Nailfold Capillaroscopy of Systemic Sclerosis: A Study of 60 Cases.
    Dave J; Mahajan S; Khadilkar P; Pradhan V
    J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
    Zanatta E; Huscher D; Ortolan A; Avouac J; Airò P; Balbir-Gurman A; Siegert E; Matucci Cerinic M; Cozzi F; Riemekasten G; Hoffmann-Vold AM; Distler O; Gabrielli A; Heitmann S; Hunzelmann N; Montecucco C; Morovic-Vergles J; Ribi C; Doria A; Allanore Y;
    Rheumatology (Oxford); 2022 Nov; 61(12):4786-4796. PubMed ID: 35348643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
    Chepy A; Bourel L; Koether V; Launay D; Dubucquoi S; Sobanski V
    Front Immunol; 2022; 13():930970. PubMed ID: 35837382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Laboratory Characteristics and Mortality in Korean Patients with Systemic Sclerosis: A Nationwide Multicenter Retrospective Cohort Study.
    Moon KW; Lee SS; Lee YJ; Jun JB; Yoo SJ; Ju JH; Chang SH; Choi IA; Kang TY; Lee EB; Lee SG
    J Rheumatol; 2018 Aug; 45(9):1281-1288. PubMed ID: 30008455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and serological features of systemic sclerosis in a Chinese cohort.
    Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
    Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
    Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
    Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinuclear antibody in systemic sclerosis (scleroderma).
    Okano Y
    Rheum Dis Clin North Am; 1996 Nov; 22(4):709-35. PubMed ID: 8923592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
    Fischer A; Pfalzgraf FJ; Feghali-Bostwick CA; Wright TM; Curran-Everett D; West SG; Brown KK
    J Rheumatol; 2006 Aug; 33(8):1600-5. PubMed ID: 16783860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical importance of gastroesophageal reflux in Chinese patients with systemic sclerosis.
    Liu X; Li M; Xu D; Hou Y; Wang Q; Tian Z; Sun Q; Zeng X
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S60-6. PubMed ID: 22691211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scleroderma autoantibodies in guiding monitoring and treatment decisions.
    Shah S; Denton CP
    Curr Opin Rheumatol; 2022 Nov; 34(6):302-310. PubMed ID: 36082759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
    Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.
    Kuwana M; Kaburaki J; Okano Y; Tojo T; Homma M
    Arthritis Rheum; 1994 Jan; 37(1):75-83. PubMed ID: 8129766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.
    Sulli A; Ruaro B; Smith V; Pizzorni C; Zampogna G; Gallo M; Cutolo M
    J Rheumatol; 2013 May; 40(5):634-9. PubMed ID: 23457379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on pulmonary complications of systemic sclerosis in eastern India.
    Ghosh A; Banerjee A; Biswas AK
    Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic and prognostic value of a line immunoblot assay in Taiwanese patients with systemic sclerosis.
    Yen TH; Chen JP; Hsieh TY; Hung WT; Lai KL; Hsieh CW; Chen HH; Huang WN; Chen YH; Chen YM
    Clin Chim Acta; 2023 Jul; 547():117457. PubMed ID: 37390945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort.
    Fretheim H; Halse AK; Seip M; Bitter H; Wallenius M; Garen T; Salberg A; Brunborg C; Midtvedt Ø; Molberg Ø; Hoffmann-Vold AM
    Rheumatology (Oxford); 2020 Oct; 59(10):2920-2929. PubMed ID: 32097470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Features and Risk Factors of Rapidly Progressive Systemic Sclerosis in a Single Center in China: Anti-RNA Polymerase III Antibodies as a Predictor.
    Yu Q; Zhang J; Fan L; Yu T; Liu B; Ding J
    Discov Med; 2023 Apr; 35(175):193-200. PubMed ID: 37105929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.